PRESS RELEASE Clinically validated on-device app delivers smartphone-level simplicity with built-in safety controls March 9th, 2026 – Cleveland, OH — Phothera, the leading manufacturer of FDA-cleared light therapy devices for chronic skin conditions including vitiligo, psoriasis, atopic dermatitis, and cutaneous T-cell lymphoma (CTCL), today announced the availability of Guided Mode, a next-generation on-device app designed to simplify and standardize home phototherapy. Guided […]
View More
Landmark LITE Study Confirms Home UVB Light Therapy Is as Effective as In-Office Care The LITE Study, a multi-year, randomized clinical trial led by Dr. Joel Gelfand, has released promising preliminary results: home phototherapy is just as effective as in-office treatments for plaque and guttate psoriasis. “Top-line results of the study showed that treatment at […]
View More
The American Academy of Dermatology (AAD) and the National Psoriasis Foundation (NPF) have jointly released updated clinical guidelines that reinforce the use of phototherapy as a highly effective treatment for moderate to severe psoriasis. The guidelines highlight phototherapy’s value as both a first-line therapy and a complementary option for patients who cannot tolerate systemic or […]
View More